SCHEMBL15912886

SCHEMBL15912886

CC(C)(C)c1ccc(Br)cc1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.54
CCR5 P51681 4/20 0.52
LMNA P02545 3/20 0.51
SLC6A4 P31645 1/20 0.50
MRGPRX4 Q96LA9 1/20 0.50
RXRA P19793 1/20 0.50
RXRB P28702 1/20 0.50
RXRG P48443 1/20 0.50
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 1/20 0.49
MAOB P27338 1/20 0.49
USP28 Q96RU2 1/20 0.46
USP25 Q9UHP3 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
HTT P42858 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5367447 0.88 PTGDR2 (0.60) ALOX5APCCR5LMNASLC6A4RXRA
SCHEMBL4642584 0.83 ALOX5AP (0.55) ALOX5APLMNAMRGPRX4RXRARXRB
SCHEMBL19404699 0.81 ALOX5AP (0.61) ALOX5APMRGPRX4RXRARXRBRXRG
SCHEMBL6530691 0.80 PTGDR2 (0.56) CCR5LMNASLC6A4RXRARXRB
SCHEMBL31644088 0.80 SLC6A4 (0.66) CCR5LMNASLC6A4ALDH1A1RAB9A
SCHEMBL9446223 0.80 RXRA (0.71) ALOX5APMRGPRX4RXRARXRBRXRG
SCHEMBL368071 0.80 SLC6A4 (0.66) CCR5LMNASLC6A4ALDH1A1RAB9A
SCHEMBL18587641 0.79 ALOX5AP (0.46) ALOX5APCCR5LMNAMRGPRX4RXRA
SCHEMBL15197125 0.79 CCR5 (0.54) CCR5LMNASLC6A4RXRARXRB
SCHEMBL1584529 0.79 SLC6A4 (0.54) CCR5SLC6A4ALDH1A1RAB9AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951169-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-08-28 EP disclosed
US-9926333-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2018-03-27 US disclosed
US-20170327514-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-11-16 US disclosed
US-9732093-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-15 US disclosed
US-20150368270-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-24 US disclosed
US-20150252008-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-10 US disclosed
US-9073876-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-07 US disclosed
US-20140221310-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327514-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885CCR5 394/4885LMNA 3996/4885
US-20140221310-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885CCR5 370/4885LMNA 4150/4885
US-20150368270-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885CCR5 394/4885LMNA 3996/4885
US-20150252008-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885CCR5 370/4885LMNA 4150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.